It is a life sciences foreign private limited company based in Hyderabad, Telangana, India, established in 2008.
2008 | Hyderabad, Telangana, India | Struck OffItero Biopharmaceuticals Private Limited, a struck off foreign private limited company, was established on 13 February 2008 in Hyderabad, Telangana, India. Engaging in biotechnology within the life sciences sector, it holds CIN: U24232TG2008FTC057579. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Jagannath Venkat Samavedam (Director), Ravi Babulal Jain (Additional Director). Past directors included Ramesh Alur, Aditya Kapil. Its latest AGM occurred on 30 September 2011, with the balance sheet filed on 31 March 2011. It is based at Ventureast Plaza, Plot No 40 & 41, Sy.No.115/1 Financial District , Nanakramguda, Gachi, Bowli Post, Hyderabad, Telangana, 500032.
U24232TG2008FTC057579
057579
13 February 2008
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Itero Biopharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jagannath Venkat Samavedam | Director | 30 Sep 2014 | Current |
| Ravi Babulal Jain | Additional Director | 31 May 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Director | 31 May 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Itero Biopharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Itero Biopharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Itero Biopharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Itero Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Itero Biopharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jagannath Venkat Samavedam was appointed as a Director was appointed as a Director on 30 Sep 2014 & has been associated with this company since 11 years 2 months . was recorded as a recent event.
Ravi Babulal Jain was appointed as a Additional Director was appointed as a Additional Director on 31 May 2012 & has been associated with this company since 13 years 6 months . was recorded as a recent event.
Progress on Itero Biopharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2011 as per latest MCA records. was documented.
The activity Itero Biopharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Hyderabad. was completed.
Itero Biopharmaceuticals Private Limited was registered on 13 Feb 2008 with Roc Hyderabad & aged 17 years 9 months as per MCA records. was recorded as a recent event.
The CIN of Itero Biopharmaceuticals Private Limited is U24232TG2008FTC057579.
Itero Biopharmaceuticals Private Limited is headquartered at Ventureast Plaza, Plot No 40 & 41, Sy.No.115/1 Financial District , Nanakramguda, Gachi, Bowli Post, Hyderabad, Telangana, 500032.
Itero Biopharmaceuticals Private Limited was incorporated on 13 February 2008.
The current directors of Itero Biopharmaceuticals Private Limited are
The primary industry of Itero Biopharmaceuticals Private Limited is Life Sciences.
Itero Biopharmaceuticals Private Limited is unlisted.
The authorized capital of Itero Biopharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX